XML 20 R10.htm IDEA: XBRL DOCUMENT v3.25.3

Supplemental Financial Data

9 Months Ended

Sep. 30, 2025

Supplemental Financial Data [Abstract]

Supplemental Financial Data

3. Supplemental Financial Data

Inventories

Our inventories consisted of the following (in thousands):

		September 30, 2025				December 31, 2024
Raw materials	$	424			$	5,557
Work in process		26,139				6,679
Finished goods		549			$	276
Total	$	27,112				12,512
Reported as:
Inventories	$	10,470			$	12,512
Deposits and other assets		16,642				-
Total	$	27,112			$	12,512

We classify inventories as non-current assets when we expect the inventories to remain on hand beyond one year. We include non-current inventories in deposits and other assets in our condensed consolidated balance sheets. The amount reported as deposits and other assets as of September 30, 2025 consists of work in process inventory.

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

		September 30, 2025				December 31, 2024
Clinical expenses	$	54,842			$	77,436
In-licensing expenses		7,770				7,951
Commercial expenses		15,017				3,589
Other miscellaneous expenses		21,681				19,462
Total accrued liabilities	$	99,310			$	108,438

X

- References

No definition available.

+ Details

Name:	ions_SupplementalFinancialDataAbstract
Namespace Prefix:	ions_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration